GANGLIONEUROBLASTOMA, NODULAR
Clinical trials for GANGLIONEUROBLASTOMA, NODULAR explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA, NODULAR trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, NODULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for kids with rare cancer: new drug combo shows promise
Disease control Recruiting nowThis study tests whether adding the drug dinutuximab to standard chemotherapy and other treatments helps children with high-risk neuroblastoma live longer without their cancer returning. About 478 children with newly diagnosed high-risk neuroblastoma will be randomly assigned to …
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:04 UTC
-
New hope for kids with tough cancer: targeted radiation or pill added to standard care
Disease control Recruiting nowThis study tests whether adding a radioactive drug (131I-MIBG) or a targeted pill (lorlatinib) to standard therapy helps children with high-risk neuroblastoma live longer without the cancer coming back. About 750 children and young adults (ages 1 to 30) with newly diagnosed high-…
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 22, 2026 13:53 UTC